Venous Occlusion And Classic Patient-bleeding [Nutrition]

Prev: Poorly Ascribed Potassium Levels
Next: ebooks share lits 44

From: ironjustice on 29 Jul 2008 17:36

From: ironjustice on 29 Jul 2008 17:43

On Jul 29, 2:36 pm, ironjustice <ironjust...(a)cashette.com> wrote:well-
tolerated.
Polycythemia vera, hereditary hemochromatosis, complicated sickle-
cell-
disease and retinal venous occlusion are the main clinical
applications. <<

I forgot to mention ..

Notice the .. **coincidence** OF .. iron loading diseases
Polycythemia vera, hereditary hemochromatosis, complicated sickle-cell-
disease and the incidence of venous occlusion in .. lupus ..

"Increased red blood cells are NOT .. involved in lupus" .. according
to .. them.

Science seems to deny that .. but .. who needs .. science ..
"We got .. books .. and potassium and mishandled hemolysis ridden
blood tests which are disregarded because we are incompetent
fools" .. / them ..

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://tinyurl.com/2r2nkh

Man Is A Herbivore!
http://tinyurl.com/4rq595

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk

> [Therapeutic erythrocytapheresis: Technical aspects and clinical
> applications.]
> Poullin P, Lefèvre P
> Rev Med Interne 2007 Nov 20.
>
> PURPOSE:
> Therapeutic erythrocytapheresis is a selective red cell-depletion
> aphaeresis technique.
> CURRENT KNOWLEDGE AND KEY POINT:
> Using a discontinuous or continuous flow blood cell separator, the
> technique safely allows quickly and automatically collecting a large
> volume of red cells. The main obstacle of implementation is a poor
> peripheral venous access. The procedure is well-tolerated.
> Polycythemia vera, hereditary hemochromatosis, complicated sickle-cell-
> disease and retinal venous occlusion are the main clinical
> applications. PROSPECT AND PROJECT:
> Therapeutic erythrocytapheresis is a more modern and more effective
> method than the classic patient-bleeding. It has to be preferred in
> the early treatment of patients with polycythemia vera and hereditary
> hemochromatosis.
> ----------------------
> Article
> Central retinal vein occlusion complicating systemic lupus
> erythematosus
> Michael Silverman, M.D. *, Marvin J. Lubeck, M.D., F.A.C.S., Walter G.
> Briney, M.D.
> Departments of Medicine, Division f Rheumatology, and Surgery,
> Division of Ophthalmology, University of Colorado Medical Center, and
> the Arthritis Treatment Center, General Rose Memorial Hospital,
> Denver, Colorado.
>
> *Correspondence to Michael Silverman, University of Colorado Medical
> Center, 4200 East Ninth Avenue, Box B115, Denver, Colorado 80262
>
> Abstract
> Retinal lesions occur in 25 to 30% of patients with systemic lupus
> erythematosus (SLE). Visual loss, however, is rare. A patient who
> developed central retinal vein occlusion and blindness during the
> course of active SLE is described. The pertinent literature is
> reviewed with attention to possible pathophysiologic mechanisms.
>
> --------------------------------------------------------------------------------
> Received: 9 February 1978; Accepted: 16 March 1978
> Digital Object Identifier (DOI)
>
> Who loves ya.
> Tom
>
> Jesus Was A Vegetarian!http://tinyurl.com/2r2nkh
>
> Man Is A Herbivore!http://tinyurl.com/4rq595
>
> DEAD PEOPLE WALKINGhttp://tinyurl.com/zk9fk

From: ironjustice on 30 Jul 2008 22:23

On Jul 29, 2:43 pm, ironjustice <ironjust...(a)cashette.com>
wrote:erythrocytapheresis <<

Erythrocytapheresis is the removal of red blood cells.
Modern day bloodletting.

Hemodilution is also called .. modern day bloodletting .. and
surprise .. it TOO works.

"Hemodilution may offer a therapeutic approach to this pathology"

[Treatment of central retinal vein occlusion by isovolemic
hemodilution ]
Dec 2007
J Douat,E Ancele,M Cournot,V Pagot-Mathis,A Mathis,J C Quintyn
PURPOSE:
Evaluate the effects of hemodilution in the treatment of central
retinal vein occlusion (CRVO).
PATIENTS AND METHODS:
We carried out a retrospective, noncomparative study of 25 patients
presenting unilateral CRVO, treated with one to three hemodilution
sessions. The patients were re-examin... ( view more )ed in the 1st,
2nd, 3rd, 6th and 12th months following treatment with measurement of
visual acuity, fluorescein angiography, and optical coherence
tomography.
RESULTS:
Our study included 17 men and eight women, averaging 63 years of age
(range, 35-87 years), and monitored for an average of 7 months (range,
3-12 months). After the 6th month following treatment, average visual
acuity improved compared to initial visual acuity. Initial visual
acuity of less than 1/10, with the existence of poorly irrigated areas
in the angiography, presented negative prognosis factors. The number
of hemodilutions did not produce a significant difference in final
visual acuity. No serious complications due to hemodilution were
observed. DISCUSSION:
Treatment of CRVO is subject to debate. Some practitioners recommend
against treatment, while others advocate intervention and offer laser-
induced chorioretinal venous anastomosis. Surgical vitrectomy and
radial optical neurotomy, with or without injection of triamcinolone,
await evaluation. Hemodilution may offer a therapeutic approach to
this pathology, in which the etiopathogenesis is not yet recognized,
but in which blood viscosity plays a key role. This treatment is well
tolerated.
CONCLUSION:
Hemodilutions appear to have beneficial effects in treating CRVO,
whatever the number of hemodilutions used. This study should be
confirmed by a prospective study using an untreated control group.

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://tinyurl.com/2r2nkh

Man Is A Herbivore!
http://tinyurl.com/4rq595

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk

> On Jul 29, 2:36 pm, ironjustice <ironjust...(a)cashette.com> wrote:well-
> tolerated.
> Polycythemia vera, hereditary hemochromatosis, complicated sickle-
> cell-
> disease and retinal venous occlusion are the main clinical
> applications. <<
>
> I forgot to mention ..
>
> Notice the .. **coincidence** OF .. iron loading diseases
> Polycythemia vera, hereditary hemochromatosis, complicated sickle-cell-
> disease and the incidence of venous occlusion in .. lupus ..
>
> "Increased red blood cells are NOT .. involved in lupus" .. according
> to .. them.
>
> Science seems to deny that .. but .. who needs .. science ..
> "We got .. books .. and potassium and mishandled hemolysis ridden
> blood tests which are disregarded because we are incompetent
> fools" .. / them ..
>
> Who loves ya.
> Tom
>
> Jesus Was A Vegetarian!http://tinyurl.com/2r2nkh
>
> Man Is A Herbivore!http://tinyurl.com/4rq595
>
> DEAD PEOPLE WALKINGhttp://tinyurl.com/zk9fk
>
>
>
> > [Therapeutic erythrocytapheresis: Technical aspects and clinical
> > applications.]
> > Poullin P, Lefèvre P
> > Rev Med Interne 2007 Nov 20.
>
> > PURPOSE:
> > Therapeutic erythrocytapheresis is a selective red cell-depletion
> > aphaeresis technique.
> > CURRENT KNOWLEDGE AND KEY POINT:
> > Using a discontinuous or continuous flow blood cell separator, the
> > technique safely allows quickly and automatically collecting a large
> > volume of red cells. The main obstacle of implementation is a poor
> > peripheral venous access. The procedure is well-tolerated.
> > Polycythemia vera, hereditary hemochromatosis, complicated sickle-cell-
> > disease and retinal venous occlusion are the main clinical
> > applications. PROSPECT AND PROJECT:
> > Therapeutic erythrocytapheresis is a more modern and more effective
> > method than the classic patient-bleeding. It has to be preferred in
> > the early treatment of patients with polycythemia vera and hereditary
> > hemochromatosis.
> > ----------------------
> > Article
> > Central retinal vein occlusion complicating systemic lupus
> > erythematosus
> > Michael Silverman, M.D. *, Marvin J. Lubeck, M.D., F.A.C.S., Walter G.
> > Briney, M.D.
> > Departments of Medicine, Division f Rheumatology, and Surgery,
> > Division of Ophthalmology, University of Colorado Medical Center, and
> > the Arthritis Treatment Center, General Rose Memorial Hospital,
> > Denver, Colorado.
>
> > *Correspondence to Michael Silverman, University of Colorado Medical
> > Center, 4200 East Ninth Avenue, Box B115, Denver, Colorado 80262
>
> > Abstract
> > Retinal lesions occur in 25 to 30% of patients with systemic lupus
> > erythematosus (SLE). Visual loss, however, is rare. A patient who
> > developed central retinal vein occlusion and blindness during the
> > course of active SLE is described. The pertinent literature is
> > reviewed with attention to possible pathophysiologic mechanisms.
>
> > --------------------------------------------------------------------------------
> > Received: 9 February 1978; Accepted: 16 March 1978
> > Digital Object Identifier (DOI)
>
> > Who loves ya.
> > Tom
>
> > Jesus Was A Vegetarian!http://tinyurl.com/2r2nkh
>
> > Man Is A Herbivore!http://tinyurl.com/4rq595
>
> > DEAD PEOPLE WALKINGhttp://tinyurl.com/zk9fk- Hide quoted text -
>
> - Show quoted text -

From: ferrous on 31 Jul 2008 11:51

"Modern day bloodletting.

Hemodilution is also called .. modern day bloodletting .. and
surprise .. it TOO works."

And it works by:

"blood viscosity"

being lowered, nothing to do with tissue iron levels, nary a spec of
"rust" in sight It's a pun son, a pun..

Jesus ate a mediterranean diet.

From: ironjustice on 31 Jul 2008 20:32

[Therapeutic erythrocytapheresis: Technical aspects and clinical
applications.]
Poullin P, Lefèvre P
Rev Med Interne 2007 Nov 20.

PURPOSE:
Therapeutic erythrocytapheresis is a selective red cell-depletion
aphaeresis technique.
CURRENT KNOWLEDGE AND KEY POINT:
Using a discontinuous or continuous flow blood cell separator, the
technique safely allows quickly and automatically collecting a large
volume of red cells. The main obstacle of implementation is a poor
peripheral venous access. The procedure is well-tolerated.
Polycythemia vera, hereditary hemochromatosis, complicated sickle-
cell-
disease and retinal venous occlusion are the main clinical
applications. PROSPECT AND PROJECT:
Therapeutic erythrocytapheresis is a more modern and more effective
method than the classic patient-bleeding. It has to be preferred in
the early treatment of patients with polycythemia vera and hereditary
hemochromatosis.
----------------------
Central retinal vein occlusion complicating systemic lupus
erythematosus
Michael Silverman, M.D. *, Marvin J. Lubeck, M.D., F.A.C.S., Walter
G.
Briney, M.D.
Departments of Medicine, Division f Rheumatology, and Surgery,
Division of Ophthalmology, University of Colorado Medical Center, and
the Arthritis Treatment Center, General Rose Memorial Hospital,
Denver, Colorado.

*Correspondence to Michael Silverman, University of Colorado Medical
Center, 4200 East Ninth Avenue, Box B115, Denver, Colorado 80262

Abstract
Retinal lesions occur in 25 to 30% of patients with systemic lupus
erythematosus (SLE). Visual loss, however, is rare. A patient who
developed central retinal vein occlusion and blindness during the
course of active SLE is described. The pertinent literature is
reviewed with attention to possible pathophysiologic mechanisms.

Received: 9 February 1978; Accepted: 16 March 1978
Digital Object Identifier (DOI)
-------------------------

Notice the .. **coincidence** OF .. iron loading diseases
Polycythemia vera, hereditary hemochromatosis, complicated sickle-
cell-
disease and the incidence of venous occlusion in .. lupus ..

"Increased red blood cells are NOT .. involved in lupus" .. according
to .. them.

Science seems to deny that .. but .. who needs .. science ..
"We got .. books .. and potassium and mishandled hemolysis ridden
blood tests which are disregarded because we are incompetent
fools" .. / them ..
--------------------

Erythrocytapheresis is the removal of red blood cells.
Modern day bloodletting.

Hemodilution is also called .. modern day bloodletting .. and
surprise .. it TOO works.

"Hemodilution may offer a therapeutic approach to this pathology"

[Treatment of central retinal vein occlusion by isovolemic
hemodilution ]
Dec 2007
J Douat,E Ancele,M Cournot,V Pagot-Mathis,A Mathis,J C Quintyn
PURPOSE:
Evaluate the effects of hemodilution in the treatment of central
retinal vein occlusion (CRVO).
PATIENTS AND METHODS:
We carried out a retrospective, noncomparative study of 25 patients
presenting unilateral CRVO, treated with one to three hemodilution
sessions. The patients were re-examin... ( view more )ed in the 1st,
2nd, 3rd, 6th and 12th months following treatment with measurement of
visual acuity, fluorescein angiography, and optical coherence
tomography.
RESULTS:
Our study included 17 men and eight women, averaging 63 years of age
(range, 35-87 years), and monitored for an average of 7 months
(range,
3-12 months). After the 6th month following treatment, average visual
acuity improved compared to initial visual acuity. Initial visual
acuity of less than 1/10, with the existence of poorly irrigated
areas
in the angiography, presented negative prognosis factors. The number
of hemodilutions did not produce a significant difference in final
visual acuity. No serious complications due to hemodilution were
observed. DISCUSSION:
Treatment of CRVO is subject to debate. Some practitioners recommend
against treatment, while others advocate intervention and offer
laser-
induced chorioretinal venous anastomosis. Surgical vitrectomy and
radial optical neurotomy, with or without injection of triamcinolone,
await evaluation. Hemodilution may offer a therapeutic approach to
this pathology, in which the etiopathogenesis is not yet recognized,
but in which blood viscosity plays a key role. This treatment is well
tolerated.
CONCLUSION:
Hemodilutions appear to have beneficial effects in treating CRVO,
whatever the number of hemodilutions used. This study should be
confirmed by a prospective study using an untreated control group.
Who loves ya.
Tom

Jesus Was A Vegetarian!
http://tinyurl.com/2r2nkh

Man Is A Herbivore!
http://tinyurl.com/4rq595

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk

|
Pages: 1
Prev: Poorly Ascribed Potassium Levels
Next: ebooks share lits 44